Advanced search
Start date
Betweenand


Lipid adjuvants as carriers for tuberculosis DNA vaccine

Full text
Author(s):
Lucimara Gaziola de la Torre
Total Authors: 1
Document type: Doctoral Thesis
Press: Campinas, SP.
Institution: Universidade Estadual de Campinas (UNICAMP). Faculdade de Engenharia Química
Defense date:
Examining board members:
Maria Helena Andrade Santana; Celio Lopes Silva; Clovis Ryuichi Nakaie; Francisco Benedito Teixeira Pessine; Maria Palmira Daflon Gremião; Marisa Masumi Beppu
Advisor: Maria Helena Andrade Santana
Abstract

This work contributes to the technological development of a gene vaccine against tuberculosis, where DNA is transported within liposomes. The three main aspects focused on were: 1. Functional lipid structures for DNA delivery were prepared and characterized in the attempt to obtain immunization standards against tuberculosis; 2. The best lipid structure was chosen from in vitro and in vivo assays performed in the ¿Centro de Pesquisas em Tuberculose de Ribeirão Preto¿ ¿ CPT-RP. A synthetic peptide that promotes nuclear transport was complexed to DNA and included into the best lipid structure. 3. Scale up analysis for the production of the best lipid structure that was used for DNA delivery. Two types of liposomes were composed by lipids with the following properties: (i) structure, (ii) DNA incorporation and electrostatic attraction with cell surface, and (iii) helper, that facilitates the DNA release to the citosol. These structures were prepared by the dehydrated-hydrated method, generating DRVs (dehydrated-hydrated vesicles). The DNA was associated in the inner compartment, [DRV(DNA)], or mostly at the surface [DRV-DNA] of these structures. The third structure, a lipid aggregate that does not form liposomes and was named lipoplex, was prepared in the absence of the structural lipid, used in previous preparations, which contained DNA associated with all of the aggregate¿s surface. The physico-chemical characterization of the structures were based on the hydrodynamic diameter and size distribution of the lipid particles, charge ratio for DNA incorporation into the lipid structure, surface charge, phase transition temperatures, the fluorescent probe accessibility to DNA and morphology of the particles. A synthetic peptide, with non-conventional sequence was associated to the DRV-DNA structure. The scale up for the liposome production was analyzed through the acquisition of experimental data and mathematical simulation of the liposomes production in a multitubular system. The results demonstrate that the incorporation of DNA into a lipid structure is very promising as a tuberculosis vaccine, especially in regards to the complexation of DNA with empty DRVs. The technological aspects of scaling up also confirm the viability of preformed liposomes production (AU)